Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 752 of 1,261
  1. EP 2875810

    Pharmakologische Behandlung von Zwangsstörungen unter Verwendung von Stiripentol oder einer ähnlichen Verbindung

    BIOCODEX [FR] · Granted May 27, 2015 · Expires May 22, 2035

    granted
  2. US 9040658

    Thiol-selective water-soluble polymer derivatives

    Nektar Therapeutics · Granted May 26, 2015 · Expires May 21, 2035

    granted
  3. US 9040061

    Topical formulation for administering a compound

    Rigel Pharmaceuticals, Inc. · Granted May 26, 2015 · Expires May 21, 2035

    granted
  4. US 9040522

    6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD

    Takeda Pharmaceutical Company Limited · Granted May 26, 2015 · Expires May 21, 2035

    granted
  5. CA 2866861

    TRAITEMENT DES MIGRAINES CHRONIQUES PAR INHALATION D'OXYGENE

    AIR LIQUIDE SANTE INT [FR] · Granted May 26, 2015 · Expires May 21, 2035

    granted
  6. US 9040550

    2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted May 26, 2015 · Expires May 21, 2035

    granted
  7. US 9040721

    Halogenated compounds for Photodynamic therapy

    NANOQUANTUM SCIENCES, INC. · Granted May 26, 2015 · Expires May 21, 2035

    granted
  8. US 9040626

    Nanofibers and morphology shifting micelles

    The Regents of the University of California · Granted May 26, 2015 · Expires May 21, 2035

    granted
  9. US 9040543

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted May 26, 2015 · Expires May 21, 2035

    granted
  10. US 9040567

    BAX agonist, compositions, and methods related thereto

    The Board of Regents of the University of Texas System · Granted May 26, 2015 · Expires May 21, 2035

    granted
  11. US 9040542

    Solid forms of gyrase inhibitor (R)-1-ethyl-3-[6-fluoro-5-[2-(1-hydroxy-1-methyl-ethyl)pryimidin-5-yl]-7-(tetrahydrofuran-2-yl)-1H-benzimidazol-2-yl]urea

    Vertex Pharmaceuticals Incorporated · Granted May 26, 2015 · Expires May 21, 2035

    granted
  12. US 9040250

    Binding interaction of proanthocyanidins with bacteria and bacterial components

    United States of America as represented by the Secretary of the Air Force · Granted May 26, 2015 · Expires May 21, 2035

    granted
  13. US 9040527

    Pyrimidinediamine kinase inhibitors

    Rigel Pharmaceuticals, Inc. · Granted May 26, 2015 · Expires May 21, 2035

    granted
  14. US 9040241

    Genetic markers of mental illness

    SureGene LLC · Granted May 26, 2015 · Expires May 21, 2035

    granted
  15. US 9040233

    Methods for detecting a Mycobacterium tuberculosis infection

    The United States of America, DBA The Department of Veteran Affairs · Granted May 26, 2015 · Expires May 21, 2035

    granted
  16. US 9040157

    Hollow nanoparticles and nanocomposites and methods of making hollow nanoparticles and nanocomposites

    The Board of Regents of the University of Texas System · Granted May 26, 2015 · Expires May 21, 2035

    granted
  17. US 9040059

    Recombinant bacterium capable of eliciting a protective immune response against C. perfringens

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted May 26, 2015 · Expires May 21, 2035

    granted
  18. US 9040060

    Hydrolytically degradable alkylene oxide based polymers

    Nektar Therapeutics · Granted May 26, 2015 · Expires May 21, 2035

    granted
  19. US 9033919

    Medical device rapid drug releasing coatings comprising oils, fatty acids, and/or lipids

    Lutonix, Inc. · Granted May 19, 2015 · Expires May 14, 2035

    granted
  20. US 9037214

    Multi-modality nanoparticles having optically responsive shape

    The Regents of the University of California · Granted May 19, 2015 · Expires May 14, 2035

    granted
  21. US 9035041

    Process for triphosphate oligonucleotide synthesis

    Alnylam Pharmaceuticals, Inc. · Granted May 19, 2015 · Expires May 14, 2035

    granted
  22. US 9034923

    Methods for the treatment of senile dementia of the alzheimer's type

    Phenomenome Discoveries Inc. · Granted May 19, 2015 · Expires May 14, 2035

    granted
  23. US 9034903

    Acyl piperidine inhibitors of soluble epoxide hydrolase

    The Regents of the University of California · Granted May 19, 2015 · Expires May 14, 2035

    granted
  24. US 9034881

    Treatment for vitiligo

    Rigel Pharmaceuticals, Inc. · Granted May 19, 2015 · Expires May 14, 2035

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.